Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7241
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study ; volume:34 ; number:4 ; day:4 ; month:5 ; year:2020 ; pages:515-523 ; date:8.2020
Cardiovascular drugs and therapy ; 34, Heft 4 (4.5.2020), 515-523, 8.2020
- Creator
-
Langslet, Gisle
Hovingh, G. Kees
Guyton, John R.
Baccara-Dinet, Marie T.
Letierce, Alexia
Manvelian, Garen
Farnier, Michel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10557-020-06984-0
- URN
-
urn:nbn:de:101:1-2020083119071569343081
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Langslet, Gisle
- Hovingh, G. Kees
- Guyton, John R.
- Baccara-Dinet, Marie T.
- Letierce, Alexia
- Manvelian, Garen
- Farnier, Michel
- SpringerLink (Online service)
Other Objects (12)
P5.22: Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia
R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study
P5.22: Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia
R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study
P5.22: Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia